Charles River Laboratories International, Inc.
278.35USD
-2.4100 (-0.86%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,004 | 996 | 994 | 1,005 | 1,032 | 984 | 1,003 | 1,010 |
| Cost of Revenue | — | — | — | — | — | — | — | 661 |
| Gross Profit | — | — | — | — | — | — | — | 349 |
| Operating Income | 120 | 120 | -283 | 134 | 100 | 75 | -168 | 117 |
| Net Income | -1 | -15 | -277 | 54 | 52 | 25 | -214 | 70 |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.56 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)